Cargando…
Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trials
Although over 13 billion COVID-19 vaccine doses have been administered globally, the issue of whether the optimal doses are being used has received little attention. To address this question we reviewed the reports of early-phase dose-finding trials of the nine COVID-19 vaccines approved by World He...
Autores principales: | Dunn, David T., Gilson, Richard, McCormack, Sheena, McCoy, Laura E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272950/ https://www.ncbi.nlm.nih.gov/pubmed/37355453 http://dx.doi.org/10.1016/j.vaccine.2023.06.037 |
Ejemplares similares
-
Trends in licence approvals for ophthalmic medicines in the United Kingdom
por: Morgan-Warren, Peter J., et al.
Publicado: (2020) -
Agent EXPRI: Licence to Explain
por: Mosca, Francesca, et al.
Publicado: (2020) -
Obstetric Pharmacokinetic Dosing Studies are Urgently Needed
por: McCormack, Shelley A., et al.
Publicado: (2014) -
Safety and immunogenicity of two doses of quadrivalent meningococcal conjugate vaccine or one dose of meningococcal group C conjugate vaccine, both administered concomitantly with routine immunization to 12- to 18-month-old children
por: Noya, Francisco, et al.
Publicado: (2014) -
Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
por: Lemery, Steven, et al.
Publicado: (2022)